Product Information
SORE THROAT 15-3.6 MG LOZENGE is a generic product labeled by Major Pharmaceuticals, priced at $0.1454 per EA under NDC 00904625549. Its NADAC has been published 648 times since Nov 28, 2013.
Strength
15; 3.6 mg/1; mg/1
Manufacturer
Major PharmaceuticalsNDC
00904625549
Classification
Generic
Dosage Form
LOZENGE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
BENZOCAINE; MENTHOLApproval Type
OTC MONOGRAPH DRUG
FDA Application
M012On Market Since
12/28/2012
Pharmacological Classes
Price Statistics
The NADAC for SORE THROAT 15-3.6 MG LOZENGE has been published 648 times since Nov 28, 2013, and over the history we have for it it has risen 60.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1454 per EA |
|---|---|
| All-time high | $0.1593 (Sep 11, 2024) |
| All-time low | $0.0850 (Jan 19, 2022) |
| 52-week high | $0.1584 |
| 52-week low | $0.1454 |
| Median price | $0.0976 |
| Average price | $0.1085 |
| Largest weekly change | +76.7% (Aug 23, 2023) |
| Weeks tracked | 648 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of SORE THROAT 15-3.6 MG LOZENGE?
The current National Average Drug Acquisition Cost (NADAC) for SORE THROAT 15-3.6 MG LOZENGE, manufactured by Major Pharmaceuticals, is $0.1454 per EA (NDC 00904625549), effective Jun 24, 2026.
How has the price of SORE THROAT 15-3.6 MG LOZENGE changed over time?
Over the history we have for it, the NADAC for SORE THROAT 15-3.6 MG LOZENGE has risen 60.3%. It has been tracked across 648 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for SORE THROAT 15-3.6 MG LOZENGE?
Since Nov 28, 2013, the NADAC for SORE THROAT 15-3.6 MG LOZENGE has ranged from a low of $0.0850 (Jan 19, 2022) to a high of $0.1593 (Sep 11, 2024), with a median of $0.0976 per EA.
Are there cheaper alternatives to SORE THROAT 15-3.6 MG LOZENGE?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as SORE THROAT 15-3.6 MG LOZENGE, but none are currently priced below it.
Who manufactures SORE THROAT 15-3.6 MG LOZENGE?
SORE THROAT 15-3.6 MG LOZENGE (NDC 00904625549) is labeled by Major Pharmaceuticals, and CMS classifies it as a generic product.
Related Drugs
Same classification